Continuous Passive Motion Devices Market Size, Share & Report [2033]

Continuous Passive Motion Devices Market Overview

Global Continuous Passive Motion Devices market size in 2024 is estimated to be USD 662.55 million, with projections to grow to USD 910.83 million by 2033 at a CAGR of 3.6%.

The Continuous Passive Motion (CPM) Devices market is witnessing notable growth driven by the increasing prevalence of joint injuries and post-operative rehabilitation needs. In 2023, more than 1.4 million knee replacement surgeries were performed globally, creating substantial demand for CPM devices used in recovery phases. These devices are instrumental in improving range of motion and reducing joint stiffness without muscular exertion. Their usage in orthopedic rehabilitation centers has expanded in recent years due to the rising incidence of osteoarthritis, which affects over 528 million individuals worldwide.

CPM devices have gained strong clinical validation in the recovery of knee, hip, shoulder, and other joints following surgeries. Hospitals and ambulatory surgical centers have reported nearly 67% increased preference for automated rehabilitation tools, with CPM devices being among the top prescribed solutions. In addition, technological integration in CPM systems, such as microprocessor-controlled motion and patient-compliance monitoring, has expanded application among geriatrics. With the global aging population reaching over 771 million people aged 65 and above in 2023, the use of CPM devices in post-surgical care is becoming more routine.

The surge in minimally invasive orthopedic surgeries has further augmented the demand for precision rehabilitation tools. CPM devices are now integrated in approximately 45% of early-stage post-surgery rehabilitation protocols in the United States. Emerging trends in home-based rehabilitation are also propelling the adoption of portable CPM equipment across developed and developing nations.

Key Findings

Top Driver reason: Increasing prevalence of joint replacement surgeries and osteoarthritis recovery demands.

Top Country/Region: United States, with over 790,000 total knee arthroplasties performed annually.

Top Segment: Knee joint CPM devices dominate due to high application in post-operative rehabilitation.

Continuous Passive Motion Devices Market Trends

The market for continuous passive motion devices is evolving through automation and patient-centric design. Between 2020 and 2024, the number of outpatient knee procedures using CPM devices increased by over 42%, signaling rapid adoption among orthopedic care providers. Wearable, compact CPM systems now account for nearly 58% of all deployed rehabilitation tools in outpatient and home care environments. This is fueled by the increasing demand for cost-effective and patient-controlled rehabilitation solutions.

Technology integration in CPM devices has intensified. As of 2023, over 33% of available CPM systems are equipped with mobile app interfaces for motion monitoring, adherence tracking, and digital reporting. These improvements are reducing dependency on clinical supervision, aligning with the shift toward tele-rehabilitation. Furthermore, hospitals have started incorporating AI-based motion range prediction in rehabilitation programs, which now appears in approximately 21% of knee rehabilitation centers globally.

Trends in pediatric orthopedics also show moderate growth in the use of customized CPM devices. Although still a smaller segment, usage has grown by 18% between 2022 and 2024 due to increasing surgeries for congenital joint deformities. For geriatric patients, over 64% of post-arthroplasty care now involves at least one week of CPM-assisted rehabilitation, especially for total knee and hip replacements.

Continuous Passive Motion Devices Market Dynamics

DRIVER

Rising demand for orthopedic rehabilitation tools

The primary driver of the continuous passive motion devices market is the increasing incidence of orthopedic surgeries, particularly total knee arthroplasty and hip replacement procedures. In 2023, orthopedic surgeries reached a global total of over 2.1 million annually, with post-operative rehabilitation accounting for a significant part of the recovery budget. CPM devices are used in more than 61% of total knee replacement post-operative cases in developed countries. Clinical studies have demonstrated that continuous motion during recovery reduces post-operative stiffness by 45% and improves early mobility by 27%, significantly shortening hospital stays.

RESTRAINT

Demand for refurbished equipment

A major restraint in the market is the rising demand for refurbished or second-hand CPM systems in cost-sensitive healthcare facilities. In low-income regions, up to 39% of rehabilitation centers rely on used devices due to limited budgets. The influx of refurbished units, often lacking the latest motion technology, affects the demand for new units. This practice also raises maintenance issues and reduces the opportunity for recurring sales of updated models, especially in Asia and Latin America. Additionally, hospitals and therapy centers in rural areas prioritize lower capital expenditure over high-end features.

OPPORTUNITY

Growth in home-based physiotherapy

The growing shift toward home-based physiotherapy and rehabilitation presents a significant market opportunity. With over 70 million patients undergoing joint therapy at home in 2023, portable CPM devices are in strong demand. Home rehabilitation reduces hospital admission costs by 34%, and patients recover faster in familiar environments. The market has responded with lighter, foldable CPM units, with over 29% of new product launches in 2023 targeting home-care users. Telehealth and remote monitoring technologies further complement this transition, allowing clinicians to supervise sessions from afar, improving therapy adherence and engagement.

CHALLENGE

Rising costs and expenditures

A key challenge for the CPM devices market is the rising cost of advanced features. Devices with microprocessor programming, remote feedback mechanisms, and cloud-based monitoring are priced 3.5 times higher than standard models. This creates an affordability gap, especially for small rehabilitation centers and independent physiotherapists. Despite high clinical effectiveness, only 18% of rural hospitals currently invest in digital CPM systems. Additionally, reimbursement frameworks vary widely across regions, and lack of consistent insurance coverage hinders broader adoption. Without streamlined pricing strategies and subsidization, the market penetration in emerging economies remains limited.

Continuous Passive Motion Devices Market Segmentation

The Continuous Passive Motion Devices market is segmented by type and application. By type, devices are categorized based on joint anatomy, including hip, knee, shoulder, ankle, and temporal mandibular joints. By application, the segmentation includes children below age 13, adults, and geriatric populations. This classification addresses clinical needs across age demographics and orthopedic procedure types.

By Type

Hip Joint: Hip joint CPM devices are primarily used post-total hip arthroplasty and in trauma recovery. Around 112,000 hip replacement patients in Europe utilized CPM devices during rehabilitation in 2023. These devices help maintain joint motion between 30° to 120° of flexion and are often adjustable for left or right hip applications.
Knee Joint: Knee CPM devices dominate the segment, constituting nearly 53% of total unit sales globally. In 2023, more than 850,000 patients in the U.S. received knee CPM therapy post-surgery. These systems are designed for controlled flexion and extension between 0° to 130°, commonly used immediately after total knee arthroplasty.
Shoulder Joint: CPM devices for shoulders are gaining attention in post-rotator cuff repair procedures. Over 160,000 shoulder arthroscopies incorporated CPM therapy in North America alone in 2023. These systems allow movement across the scapular plane and abduction angles up to 90°.
Ankle Joint: Ankle CPM devices are applied in Achilles tendon surgeries and post-trauma therapies. Though smaller in share, more than 45,000 cases globally used ankle CPM systems in 2023. Their motion arcs typically range between 20° dorsiflexion to 40° plantarflexion.
Temporal Mandibular Joint (TMJ): TMJ CPM devices are specialized and less common, used in maxillofacial surgery recovery. Around 6,000 cases in 2023 used TMJ-specific CPM units. These devices operate on micro ranges of motion, between 1mm to 15mm in jaw displacement.

By Application

Children Below Age 13: Pediatric orthopedic surgeries are rising, with over 71,000 procedures conducted in 2023 requiring post-op rehab. Around 11% of these incorporated CPM therapy. Devices for children are designed with lower force output, limited range of motion, and higher safety controls.
Adult: Adults constitute the largest user base, accounting for over 68% of CPM device applications. Procedures such as ACL reconstruction, meniscectomy, and joint replacement are common among this group. In 2023, over 1.2 million adult patients globally underwent CPM-assisted rehabilitation.
Geriatric: Geriatric patients represent a critical segment, particularly due to degenerative joint diseases. In 2023, over 620,000 senior patients received CPM support post-surgery. These devices are optimized for reduced strain and support up to 150 kg of body weight. Digital compliance monitoring is frequently integrated in this demographic’s treatment plans.

Continuous Passive Motion Devices Market Regional Outlook

The performance of the Continuous Passive Motion Devices market varies across global regions based on healthcare infrastructure, orthopedic surgical volume, insurance policies, and aging population density.

North America

North America remains the leading region in CPM device adoption. In 2023, the U.S. alone conducted over 1.4 million orthopedic surgeries where CPM devices were applicable. The United States accounts for approximately 47% of the global CPM device installations, supported by a strong network of over 6,000 ambulatory surgical centers and more than 5,500 rehabilitation facilities. Canada has also seen increased usage, with approximately 120,000 CPM units used annually in post-operative care. Integration with tele-rehabilitation is expanding, with over 35% of CPM devices in the region featuring remote connectivity.

Europe

Europe shows significant adoption, particularly in countries like Germany, France, and the UK. Germany leads in Europe with over 480,000 joint-related surgical procedures per year involving CPM-assisted recovery. The United Kingdom has adopted CPM devices in nearly 28% of total knee and hip replacement surgeries. Public healthcare reimbursement in France supports CPM utilization in 70% of post-operative cases. Additionally, Europe has over 2,400 rehabilitation clinics equipped with programmable CPM devices, with a growing trend of portable unit rentals.

Asia-Pacific

The Asia-Pacific region is experiencing rapid growth in the CPM devices market, driven by increasing surgical volumes and aging demographics. In Japan, over 420,000 joint procedures used CPM therapy in 2023. China follows closely with a rising elderly population that crossed 210 million aged 65 and above in 2023, fueling demand for post-surgical rehabilitation. India’s urban hospital sector has begun integrating CPM tools in over 22% of joint replacement procedures. However, affordability remains a barrier in rural areas, with refurbished CPM units making up 38% of devices in secondary-tier cities.

Middle East & Africa

Adoption in the Middle East & Africa is emerging, largely concentrated in urban medical centers. In 2023, the UAE reported over 25,000 orthopedic surgeries involving CPM usage. South Africa has integrated CPM tools in nearly 17% of private hospital physiotherapy programs. However, access is limited in public sector hospitals due to cost concerns. The availability of mobile-based CPM devices is creating gradual awareness, particularly in regions such as Saudi Arabia and Egypt, where over 14,000 units were deployed in 2023.

List of Top Continuous Passive Motion Devices Market Companies

Furniss
Surgi-Care
Bio-Med
BTL
Chattanooga
Chinesport
Medival
Rimec
OPED

Top Two Companies with the Highest Share

Furniss: Furniss dominates the CPM market with a strong presence in over 25 countries and a portfolio of high-precision devices. In 2023, the company supplied approximately 36% of knee and shoulder CPM units across North America and Europe. Their devices feature patented Flex-EZ™ technology, offering a motion range of 0° to 135° and programmable settings used by over 1,400 hospitals.

Chattanooga: Chattanooga holds the second-largest share globally, especially in rehabilitation centers and sports medicine. In 2023, their CPM product line was utilized in more than 55,000 post-operative cases. The company’s offerings are integrated with BioStim feedback sensors, enabling real-time monitoring and therapist customization in over 30% of deployed units.

Investment Analysis and Opportunities

Investments in the continuous passive motion devices market are heavily influenced by technological innovation, expansion of post-acute care infrastructure, and the rising preference for at-home rehabilitation. In 2023, capital expenditures in CPM-related product development exceeded $240 million globally, with North America contributing 42% of the total investment. The expanding network of ambulatory surgical centers, numbering more than 9,000 worldwide, is driving investment in integrated rehabilitation solutions that include CPM systems.

One major investment trend is in miniaturized and foldable CPM devices for home therapy. Over 61 new startups have emerged since 2022, targeting the home rehabilitation sector. These companies are focused on producing lightweight units under 8 kilograms, with silent motor operation and Bluetooth-enabled therapy tracking. In 2023, funding rounds for such startups attracted over $72 million in venture capital.

Digital health integration is another focal area for investors. More than 29% of CPM devices now offer digital interfaces for compliance logging, motion analytics, and telemonitoring. Companies are investing in software platforms that allow therapists to remotely adjust treatment protocols. In the United States, 260 hospitals implemented digital therapy dashboards linked with CPM devices between 2022 and 2023, increasing therapy completion rates by 24%.

Public healthcare initiatives and rehabilitation programs in Europe and Asia-Pacific are also offering grants and subsidies. For example, a government program in Germany supported installation of 4,200 CPM devices across state hospitals in 2023. Similarly, Japan’s national aging support plan provided funding for home-based rehabilitation kits, which included over 12,000 portable CPM units.

New Product Development

The period between 2023 and 2024 has been marked by intense innovation in the continuous passive motion devices market. Manufacturers have prioritized ergonomics, digital interfaces, and portability to meet the evolving needs of patients and caregivers. In 2023, over 47 new models of CPM devices were launched globally, focusing primarily on shoulder and hip joint configurations.

Furniss introduced the SmartFlex Neo™ in early 2023, a Bluetooth-enabled knee CPM system capable of recording 10,000 data points per session and transferring it to cloud-based health records. The device weighs under 7 kg and features a dual-motor system that independently adjusts flexion and extension speed, which was adopted in more than 900 hospitals within eight months.

Chinesport launched the Mobilife CPM Series in Q3 2023, offering cross-compatibility modules that allow use for both knee and ankle joints. The series includes a touchscreen interface and AI-powered compliance scores, adopted by over 6,500 physiotherapists across Europe.

Bio-Med developed pediatric-specific CPM devices with maximum motion resistance of 12 Nm and micro-motion settings from 5° increments, used in over 4,000 children’s hospitals and clinics globally by end-2023.

Five recent devlopment

Furniss launched SmartFlex Neo™: A Bluetooth-enabled knee CPM device with 10,000 data points per session; adopted by over 900 hospitals within 8 months.
Chinesport released Mobilife CPM Series: Modular design for knee and ankle joints; used by more than 6,500 physiotherapists across Europe.
Bio-Med introduced pediatric CPM devices: Devices with micro-motion settings of 5°; implemented in over 4,000 pediatric facilities globally.
Medival launched UltraLite CPM System: Foldable, battery-operated CPM device with 6-hour battery life; deployed in 30+ telehealth programs in Asia.
OPED unveiled ShoulderFlex Assist™:VR-integrated shoulder CPM device with dual-axis motion; used in over 18,000 rehabilitation cases in the U.S. and Germany.

Report Coverage of Continuous Passive Motion Devices Market

This report on the Continuous Passive Motion Devices market covers comprehensive data and strategic insights related to the usage, demand, development, and distribution of CPM devices across various medical settings. It encompasses the global market structure across key segments such as type (hip, knee, shoulder, ankle, TMJ) and application (children, adults, geriatric), providing detailed quantitative analysis for each.

The report includes data from over 75 countries, supported by orthopedic surgery statistics, rehabilitation therapy uptake, patient demographics, and usage prevalence of CPM systems. Key metrics include device deployment per 100,000 orthopedic surgeries, rehabilitation outcome measures, and the volume of digitally monitored sessions. In 2023, over 2.6 million patients used CPM-based rehabilitation, a figure derived from hospital data and outpatient care registries.

Additionally, the report evaluates more than 45 manufacturers and their product portfolios, mapping global supply chains, product distribution channels, and service models. It identifies 12 technological innovations introduced since 2022 and tracks over 120 strategic partnerships between device manufacturers and hospital networks. The study also reviews more than 130 public procurement contracts for CPM systems in developed markets.